Federal Grants for Food and Nutrition



Department of Health and Human Services
 $62,853,680,968 Department of Transportation
 $56,443,571,981 Environmental Protection Agency
 $35,751,587,496 Department of Energy
 $24,661,368,000 National Aeronautics and Space Administration
 $14,032,768,821 Department of Homeland Security
 $13,986,266,741 Department of Labor
 $10,348,285,755 Department of Defense
 $10,111,366,675 Department of the Interior
 $9,806,569,960 Department of Agriculture
 $8,296,397,040 Agency for International Development
 $7,754,781,106 Department of Commerce
 $6,871,103,950 Department of Housing and Urban Development
 $6,642,477,476 Department of State
 $6,042,666,916 Department of Justice
 $5,571,395,802 Department of Education
 $2,642,831,221 Department of the Treasury
 $1,019,380,000 Other Agencies
 $724,036,487


SNAP Fraud Framework Implementation Grant Program

Food and Nutrition Service
The purpose of the SNAP Fraud Framework Implementation Grant Program is to support State agency efforts to improve and expand recipient fraud prevention, detection and investigation efforts using...more
Posted On - 2019-02-15


International Emergency Food Assistance

Agency for International Development
The U.S. Agency for International Development’s (USAID) Office of Food for Peace (FFP) is the U.S. Government (USG) leader in international food assistance. The purpose of this Annual Program...more
Posted On - 2019-02-15


Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional)

Food and Drug Administration
FDA believes that the thirty-year FDA-IIT collaboration has been a sound investment. National Center for Food Safety and Technology (NCFST) was established by IIT to bring together the food safety...more
Posted On - 2019-02-13




Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional

Food and Drug Administration
The purpose of this program is to support research activities that expand the knowledge base related to complex products and formulation development, analysis, and manufacturing control to advance...more
Posted On - 2019-02-13


Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required)

Food and Drug Administration
The purpose of this funding opportunity is to support research relevant to topical semisolid drug products that will help elucidate the relationship between a product's quality attributes and...more
Posted On - 2019-02-11


Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed)

Food and Drug Administration
The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of...more
Posted On - 2019-02-11


Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed)

Food and Drug Administration
The purpose of this funding opportunity is to support the research and development necessary to elucidate specific considerations that may be uniquely relevant to evaluating the bioequivalence (BE)...more
Posted On - 2019-02-07




Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) Activity Code

Food and Drug Administration
The purpose of this funding opportunity announcement (FOA)is to support research to develop and qualify a Patient Reported Outcome (PRO)for Non-Cystic Fibrosis Bronchiectasis (NCFB) under FDA’s...more
Posted On - 2019-02-06


Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)

Food and Drug Administration
Cardiovascular toxicity is a leading cause of drug attritionin drug development. Proarrhythmia, QT prolongation and Torsade de Point (TdP)contribute the most to this attrition and these outcomes...more
Posted On - 2019-01-31





Social Entrepreneurship
Spotlight



Philanthropub: Not Your Typical Noshery


Restaurateurs Nick Vilelle and Raj Ratwani are owners of the CAUSE gastropub, which includes a fresh menu, lively atmosphere, graffiti-inspired artwork, and a hefty beer list.






More Federal Domestic Assistance Programs


Atlantic Coastal Fisheries Cooperative Management Act | Mortgage Insurance_Homes in Urban Renewal Areas | Supportive Housing for the Elderly | Maglev Project Selection Program SAFETEA-LU | Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders